publication venue for
- Oral diadochokinetic markers of X-linked dystonia-parkinsonism.. -. 2024
- Ethnoracial differences for caregiving burden in Parkinson's disease.. -. 2023
- Sex differences for cognitive decline in progressive supranuclear palsy.. -. 2023
- Clinical trials for cognition in Parkinson's disease: Where are we and how can we do better?. -. 2023
- Sex differences in dementia with Lewy bodies: Focused review of available evidence and future directions.. -. 2023
- Physical activity intensity is associated with cognition and functional connectivity in Parkinson's disease.. 7-14. 2022
- Speech and swallowing deficits in X-Linked Dystonia-Parkinsonism.. 105-110. 2021
- Point of view: Wearable systems for at-home monitoring of motor complications in Parkinson's disease should deliver clinically actionable information.. 35-39. 2021
- Cognitive impairment in Parkinson's disease is associated with Default Mode Network subsystem connectivity and cerebrospinal fluid Aβ.. 71-78. 2021
- The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study.. 34-40. 2020
- Clinical and neuroimaging correlates of progression of mild parkinsonian signs in community-dwelling older adults.. 85-90. 2020
- Big health data and Parkinson's disease epidemiology: Challenges and opportunities.. 58-59. 2020
- McLeod syndrome: Five new pedigrees with novel mutations.. 293-299. 2019
- The virtual reality of Parkinson's disease freezing of gait: A systematic review.. 26-33. 2018
- Cognitive profile of non-demented Parkinson's disease: Meta-analysis of domain and sex-specific deficits.. 32-42. 2018
- Genetic variants related to urate and risk of Parkinson's disease.. 4-9. 2018
- Dopaminergic polymorphisms associated with medication responsiveness of gait in Parkinson's disease.. 54-60. 2017
- Markers of impaired motor and cognitive volition in Parkinson's disease: Correlates of dopamine dysregulation syndrome, impulse control disorder, and dyskinesias.. 50-56. 2017
- Parkinson's disease patient preference and experience with various methods of DBS lead placement.. 25-30. 2017
- The visual kinetic depth effect is altered with Parkinson's disease.. 97-100. 2017
- Cognitive impairment in Parkinson's disease: Association between patient-reported and clinically measured outcomes.. 107-114. 2016
- Gait function and locus coeruleus Lewy body pathology in 51 Parkinson's disease patients.. 102-106. 2016
- Early-onset Parkinson's disease due to PINK1 p.Q456X mutation--clinical and functional study.. 20:1274-8. 2014
- Markers of inflammation in prevalent and incident Parkinson's disease in the Cardiovascular Health Study.. 18:274-8. 2011
- Polymorphisms of caffeine metabolism and estrogen receptor genes and risk of Parkinson's disease in men and women.. 16:370-5. 2010
- Conjugal Parkinsonism and Parkinson disease: a case series with environmental risk factor analysis.. 16:163-6. 2009
- Sensitivity and specificity of the finger tapping task for the detection of psychogenic movement disorders.. 16:197-201. 2009
- Unraveling the role of defective genes in Parkinson's disease.. S248-9. 2007
- Visual event-related potentials under different interstimulus intervals in Parkinson's disease: relation to motor disability, WAIS-R, and regional cerebral blood flow.. 11:209-19. 2005
- Early sensory information processes are enhanced on visual oddball and S1-S2 tasks in Parkinson's disease: a visual event-related potentials study.. 9:329-40. 2003
- Event-related potentials during visual S1-S2 paradigm in multiple system atrophy: relation to morphologic changes on brain MRI measurement.. 10:93-100. 2003
- The parkinsonian neurotoxin, MPP+ induces phosphorylated c-Jun in dopaminergric neurons of mesencephalic cultures.. 8:19-22. 2001